- Previous Close
72.80 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 144.00 - Volume
0 - Avg. Volume
678,596 - Market Cap (intraday)
14.68B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
22.72 - EPS (TTM)
3.23 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 2.00 (2.75%)
- Ex-Dividend Date May 6, 2025
- 1y Target Est
102.47
Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services; and specialized centers, including eye, long term, rehabilitation, and cardiology centers, as well as stroke unit, nuclear medicine, fertility, diabetes and diabetic foot, skin care, and badana clinic. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services. In addition, the company is involved in construction and operation of hospitals, dispensaries, and special clinics; general construction of non-residential buildings including schools, hospitals, and hotels; demolition of buildings; purchase, sale, and division of land and real estate, and off-plan sales activities; operation of colleges and university institutes; and medical operation activities. Further, it wholesales medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.
www.mouwasat.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4002.SR
View MorePerformance Overview: 4002.SR
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4002.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4002.SR
View MoreValuation Measures
Market Cap
14.68B
Enterprise Value
14.93B
Trailing P/E
22.72
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.10
Price/Book (mrq)
4.11
Enterprise Value/Revenue
5.19
Enterprise Value/EBITDA
15.32
Financial Highlights
Profitability and Income Statement
Profit Margin
22.43%
Return on Assets (ttm)
8.72%
Return on Equity (ttm)
18.75%
Revenue (ttm)
2.88B
Net Income Avi to Common (ttm)
645.76M
Diluted EPS (ttm)
3.23
Balance Sheet and Cash Flow
Total Cash (mrq)
511.57M
Total Debt/Equity (mrq)
20.51%
Levered Free Cash Flow (ttm)
602.11M